340B Court Ruling Offers Manufacturers Short-Term Reprieve In Contract Pharmacy Dispute

Federal court vacates enforcement letter to Lilly from HRSA, but the decision was not completely favorable to pharma. It also offers the view that the law does not allow manufacturers to restrict 340B discounts to hospitals using multiple contract pharmacies.